# ARCTURUS THERAPEUTICS HLDGS (ARCT)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/ARCT/

- Reporting holders: 5
- Reported value: $475.4K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Green Alpha Advisors, LLC](https://holderbook.com/funds/1439207-green-alpha-advisors-llc/) | $400.2K | 29,234 | 0.3% | 7 |
| [Versant Capital Management, Inc](https://holderbook.com/funds/1735057-versant-capital-management-inc/) | $41.5K | 3,032 | 0.0% | 9 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $22.2K | 1,619 | 0.0% | 12 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $10.8K | 789 | 0.0% | 6 |
| [Marquette Asset Management, LLC](https://holderbook.com/funds/1395067-marquette-asset-management-llc/) | $671 | 49 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 5 | $475.4K |
| Q2 2026 | 137 | $174.1M |
| Q1 2026 | 126 | $190.8M |
| Q4 2025 | 125 | $149.8M |
| Q3 2025 | 143 | $543.1M |
| Q2 2025 | 148 | $345.1M |
| Q1 2025 | 146 | $287.6M |
| Q4 2024 | 149 | $458.5M |
| Q3 2024 | 165 | $625.4M |
| Q2 2024 | 173 | $661.8M |
| Q1 2024 | 182 | $1.0B |
| Q4 2023 | 171 | $849.8M |